Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cuenca-Estrella

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 31, 2013
Antifungal drug resistance mechanisms in pathogenic fungi: from bench to bedsideM Cuenca-Estrella
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 3, 2006
Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus sppE Chryssanthou, M Cuenca-Estrella
Revista Clinica Espanola|August 5, 1999
[A multicenter study on fungemia caused by yeasts in Spain (April-June, 1997). A Work Group to Study Fungemia)]J L Rodríguez-Tudela, M Cuenca-Estrella
Revista Clinica Espanola|July 13, 2001
[Medical relevance of the identification of human pathogenic fungi to species level]J L Rodríguez Tudela, M Cuenca-Estrella
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 30, 2001
Present status of the detection of antifungal resistance: the perspective from both sides of the oceanM Cuenca-Estrella, J L Rodríguez-Tudela
Bone Marrow Transplantation|September 28, 2010
Silent and prolonged Aspergillus DNAemia in oncohematological patients receiving antifungal prophylaxis: a new phenomenon with clinical implicationsY Meije, J M Aguado, M Cuenca-Estrella
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|March 29, 2014
[Clinical indications for therapeutic drug monitoring of antifungal agents. In the way for optimizing the treatment of fungal infection]E Cendejas-Bueno, M Cuenca-Estrella, A Gómez-López
Enfermedades Infecciosas Y Microbiologia Clinica|October 1, 1995
[Soft-tissue infection caused by Aeromonas hydrophila]J M Ramos, M Cuenca-Estrella, J Esteban, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1995
Pneumococcal soft-tissue infectionsM Cuenca-Estrella, J M Ramos, J Esteban, et al.
Medical Mycology|September 14, 2010
Probing the role of point mutations in the cyp51A gene from Aspergillus fumigatus in the model yeast Saccharomyces cerevisiaeL Alcazar-Fuoli, E Mellado, M Cuenca-Estrella, et al.
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 31, 2013
Antifungal drug resistance mechanisms in pathogenic fungi: from bench to bedsideM Cuenca-Estrella
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 3, 2006
Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus sppE Chryssanthou, M Cuenca-Estrella
Revista Clinica Espanola|August 5, 1999
[A multicenter study on fungemia caused by yeasts in Spain (April-June, 1997). A Work Group to Study Fungemia)]J L Rodríguez-Tudela, M Cuenca-Estrella
Revista Clinica Espanola|July 13, 2001
[Medical relevance of the identification of human pathogenic fungi to species level]J L Rodríguez Tudela, M Cuenca-Estrella
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 30, 2001
Present status of the detection of antifungal resistance: the perspective from both sides of the oceanM Cuenca-Estrella, J L Rodríguez-Tudela
Bone Marrow Transplantation|September 28, 2010
Silent and prolonged Aspergillus DNAemia in oncohematological patients receiving antifungal prophylaxis: a new phenomenon with clinical implicationsY Meije, J M Aguado, M Cuenca-Estrella
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|March 29, 2014
[Clinical indications for therapeutic drug monitoring of antifungal agents. In the way for optimizing the treatment of fungal infection]E Cendejas-Bueno, M Cuenca-Estrella, A Gómez-López
Enfermedades Infecciosas Y Microbiologia Clinica|October 1, 1995
[Soft-tissue infection caused by Aeromonas hydrophila]J M Ramos, M Cuenca-Estrella, J Esteban, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1995
Pneumococcal soft-tissue infectionsM Cuenca-Estrella, J M Ramos, J Esteban, et al.
Medical Mycology|September 14, 2010
Probing the role of point mutations in the cyp51A gene from Aspergillus fumigatus in the model yeast Saccharomyces cerevisiaeL Alcazar-Fuoli, E Mellado, M Cuenca-Estrella, et al.
Pageof 12